Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Jul 14:6:Doc02.
doi: 10.3205/tss000016.

Surgical resection and survival of patients with unsuspected single node positive lung cancer (NSCLC) invading the descending aorta

Affiliations

Surgical resection and survival of patients with unsuspected single node positive lung cancer (NSCLC) invading the descending aorta

Peter Wex et al. Thorac Surg Sci. .

Abstract

Background: Surgical treatment of non-small cell lung cancer (NSCLC) with aortic invasion is still debated.

Methods: Thirteen patients with locally advanced (T4) NSCLC and invasion of the descending aorta underwent pneumonectomy (n=9) or lobectomy (n=4) together with aorta en bloc resection and reconstruction (n=8) or subadventitial dissection (n=5), complete lymph node dissection, and had microscopic unsuspected node metastasis at N1 (n=5) and N2/3 (n=8) levels of whom 12 received radiation therapy. Clamp-and-sew was used to resect and reconstruct the aorta.

Results: Operative mortality and morbidity rate was 0% and 23%, respectively. Four patients died of systemic tumor relapse and 2 of local recurrence. Six patients were alive after a median follow-up of 40 months (range 15-125 months). Overall 5-year survival rate was 45%. Median survival time and 5-year survival rate of patients after aortic resection was 35 months and 67%, respectively, and was 17 months and 0%, respectively, after aortic subadventi-tial dissection (p=0.001). N1 and N2 nodal status adversely affected survival, but survival difference was not significant (N1 versus N2/3; 52% versus 39% at 5 years; p=0.998).

Conclusions: Aortic resection with single station node positive T4 lung cancer can achieve long-term survival. The data indicate that aortic resection-reconstruction is associated with better outcome than subadventitial dissection.

Hintergrund: Die chirurgische Behandlung nicht-kleinzelliger Lungentumore mit Aortawandinvasion wird kontrovers diskutiert.

Methoden: 13 Patienten mit lokal fortgeschrittenem (T4) nicht-kleinzelligen Lungencarcinom, tumoröser Invasion der Aorta descendens und präoperativ negativem N-Staging wurden in kurativer Intention primär operiert. Operative Prozeduren: Pneumonektomie 8-mal, Lobektomie 4-mal in Kombination mit segmental aortaler en-bloc-Resektion „clamp-and-sew“ in 8 Fällen oder subadventitieller Aortawanddissektion in 5 Fällen und systematischer Lymphknotendissektion. 12 Patienten mit definitiv solitärer, mikroskopischer Lymphknotenmetastase in N1- (n=5) oder N2-Position (n=8) erhielten eine adjuvante Radiotherapie.

Ergebnisse: Die Krankenhaus-, resp. 90-Tage-Mortalität betrug 0%, die Morbidität 23%. Im weiteren Verlauf verstarben 4 Patienten an disseminierter Metastasierung und 2 Patienten am lokalen Tumorrezidiv. Bei einem mittleren Nachbeobachtungszeitraum von 40 Monaten leben noch 6 Patienten (15–125 Monate). Die kumulativ prospektive 5-Jahresüberlebensrate der 13 Patienten betrug 45%. Die mittlere Überlebenszeit und 5-Jahresüberlebensrate nach Aortaresektion betrug 35 Monate und 67%, nach Aortawanddissektion respektive 17 Monate und 0% (p=0,001). Der N1- und N2/3-Lymphknotenstatus beeinträchtigten das Langzeitüberleben (N1 versus N2/3; 52% versus 39% nach 5 Jahren). Der Überlebensunterschied erreichte kein Signifikanzniveau (p=0,998).

Schlussfolgerungen: Bei einer lokal fortgeschrittenen Lungenkrebserkrankung ist in ausgewählten Fällen, auch bei Vorliegen einer solitären Lymphknotenmetastase, mit einer primären, erweiterten Resektionstherapie ein Langzeitüberleben erzielbar. Nach unseren Ergebnissen ist bei umschriebener aortaler Infiltration der aortalen en-bloc-Resektion gegenüber der subadventitiellen Aortawanddissektion der Vorzug zu geben. Weitere Studien sollten den Nutzen multimodaler Therapiekonzepte evaluieren.

Keywords: aortic operation; lung cancer surgery; off pump; outcomes.

PubMed Disclaimer

Figures

Table 1
Table 1. Literature research: aortic resection for lung cancer (1989–2005)
Table 2
Table 2. Patients demographics
Table 3
Table 3. Operative characteristics of the 8 patients who underwent resection and reconstruction for T4 lung cancer
Table 4
Table 4. Recurrence
Figure 1
Figure 1. (A) Chest computed tomographic (CT) scan at the level (Th V) of the descending aorta, demonstrating aortic invasion (arrow) of a centrally located tumor. (B) The CT scan of the level of six thoracic vertebra shows a tumor abutting the descending aorta (arrow) .
Figure 2
Figure 2. Operative findings showing localized tumor invasion of the aortic media (arrow). The left lower lobe (LLL) is detached. The left upper lobe (LUL) is in situ and anastomosed by double sleeve (not shown).
Figure 3
Figure 3. Operative view.
(A) Tumor removed from the descending aorta by subadventitial dissection (arrow). (B) Graft replacement of the descending aorta (arrow); lung removed. Bronchus (Br) cut and closed by manual sutures.
Figure 4
Figure 4. Survival of patients after aortic resection (n=8; solid line) and subadventitial dissection (n=5; dotted line) for T4 lung cancer with aortic involvement. There was a significant difference in the 5-year survival rate (p=0.001).
Figure 5
Figure 5. Survival of patients with T4 non small cell lung cancer invading the thoracic aorta, grouped by nodal status. The 5 year survival rate were 52% and 39% for N1 and N2/N3, respectively (p=0.998).

Similar articles

Cited by

References

    1. Burt ME, Pomerantz AH, Bains MS, McCormack PM, Kaiser LR, Hilaris BS, Martini N. Results of surgical treatment of stage III lung cancer invading the mediastinum. Surg Clin North Am. 1987;67(5):987–1000. - PubMed
    1. Martini N, Yellin A, Ginsberg RJ, Bains MS, Burt ME, McCormack PM, Rusch VW. Management of non-small cell lung cancer with direct mediastinal involvement. Ann Thorac Surg. 1994;58(5):1447–1451. - PubMed
    1. Dartevelle PG. Herbert Sloan Lecture. Extended operations for the treatment of lung cancer. Ann Thorac Surg. 1997;63(1):12–19. - PubMed
    1. Rice TW, Blackstone EH. Radical resections for T4 lung cancer. Surg Clin North Am. 2002;82(3):573–587. doi: 10.1016/S0039-6109(02)00017-8. Available from: http://dx.doi.org/10.1016/S0039-6109(02)00017-8. - DOI - DOI - PubMed
    1. Cerfolio RJ, Bryant AS. Survival of patients with unsuspected N2 (stage IIIA) nonsmall-cell lung cancer. Ann Thorac Surg. 2008;86(2):362–366. doi: 10.1016/j.athoracsur.2008.04.042. Available from: http://dx.doi.org/10.1016/j.athoracsur.2008.04.042. - DOI - DOI - PubMed